NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 248 filers reported holding NEKTAR THERAPEUTICS in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $84,000 | -92.2% | 15,596 | -80.5% | 0.01% | -87.5% |
| Q4 2021 | $1,082,000 | +177.4% | 80,101 | +269.2% | 0.04% | +100.0% |
| Q3 2021 | $390,000 | -81.4% | 21,696 | -82.2% | 0.02% | -77.8% |
| Q2 2021 | $2,095,000 | +810.9% | 122,111 | +960.6% | 0.09% | +592.3% |
| Q1 2021 | $230,000 | +10.6% | 11,513 | -6.1% | 0.01% | -23.5% |
| Q4 2020 | $208,000 | -34.2% | 12,262 | -35.5% | 0.02% | -50.0% |
| Q3 2020 | $316,000 | +17.9% | 19,020 | +29.4% | 0.03% | +112.5% |
| Q3 2019 | $268,000 | – | 14,696 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rhenman & Partners Asset Management AB | 508,000 | $6,132,000 | 1.80% |
| Bodri Capital Management, LLC | 250,000 | $3,018,000 | 1.46% |
| Granahan Investment Management | 3,442,980 | $41,557,000 | 1.28% |
| TIRSCHWELL & LOEWY INC | 603,441 | $7,284,000 | 1.22% |
| NEA Management Company, LLC | 1,825,600 | $22,035,000 | 1.12% |
| Cormorant Asset Management, LP | 450,000 | $5,432,000 | 1.12% |
| HARVEY CAPITAL MANAGEMENT INC | 221,750 | $2,676,000 | 1.05% |
| Cheyne Capital Management (UK) LLP | 229,577 | $2,772,000 | 0.99% |
| Artal Group S.A. | 1,650,000 | $19,916,000 | 0.73% |
| FIC CAPITAL INC | 147,293 | $1,778,000 | 0.71% |